Longitudinal AddiQoL scores may identify higher risk for adrenal crises in Addison's disease
- PMID: 29388043
- DOI: 10.1007/s12020-017-1513-0
Longitudinal AddiQoL scores may identify higher risk for adrenal crises in Addison's disease
Abstract
Purpose: Several studies have shown a reduced quality of life (QoL) in patients with Addison's disease (AD), but investigations of QoL over a long-term course are lacking. Adrenal crises (AC) are life-threatening complications in AD. The purpose of this prospective study was to test whether the repeated use of QoL-questionnaires can detect prodromal periods of an AC.
Methods: 110 patients with AD were asked to complete the disease specific-QoL questionnaire AddiQoL and a short questionnaire about adverse events once monthly over a period of ten months. AC was defined if at least two of the following symptoms were reported: (a) hypotension, (b) nausea or vomiting, (c) severe fatigue, (d) documented hyponatremia, hyperkalemia, or hypoglycemia, and subsequent parenteral glucocorticoid administration was carried out.
Results: Prevalence of AC was 10.9/100 patient years. AddiQoL scores in patients with AC showed a trend (p = 0,08) to a wider fluctuation over time. Subjective precrises not meeting the criteria for AC were reported by 31 patients who had significantly lower AddiQoL scores (p = 0,018).
Conclusions: These are the first data showing the course of QoL during a period of ten months in patients with AD. Incidence of AC exceeds previous data. Our data show, that subjective precrises in AD associate with lower QoL. AC, as well as precrises affect intraindividual AddiQol-scores over time with a trend to a stronger fluctuation. Longitudinal AddiQol scores and self-reporting of precrises via patient diaries are additional clinical tools to identify higher risk for critical events.
Keywords: AddiQoL; Addison’s disease; Adrenal crises; Adrenal insufficiency.
Comment in
-
Predicting an adrenal crisis: can we do it?Endocrine. 2018 May;60(2):201-202. doi: 10.1007/s12020-018-1567-7. Epub 2018 Mar 1. Endocrine. 2018. PMID: 29497971 No abstract available.
-
Does quality of life differ in patients with Addison's disease on different glucocorticoid therapies?Endocrine. 2018 Dec;62(3):740. doi: 10.1007/s12020-018-1716-z. Epub 2018 Aug 21. Endocrine. 2018. PMID: 30132260 No abstract available.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
